{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:06:48Z","timestamp":1793934408124,"version":"4.8.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s12350-022-03133-y","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T16:21:34Z","timestamp":1668010894000},"page":"1235-1245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["99mTc-PYP SPECT and SPECT\/CT quantitation for diagnosing cardiac transthyretin amyloidosis"],"prefix":"10.1016","volume":"30","author":[{"given":"Kenneth J.","family":"Nichols","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se-Young","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Van Tosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Palestro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-022-03133-y_bib1","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1007\/s12350-022-03133-y_bib2","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis","volume":"1","author":"Castano","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1007\/s12350-022-03133-y_bib3","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/ HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2- evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03133-y_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99m)Tc pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-022-03133-y_bib5","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s12350-020-02205-1","article-title":"Tc-99m-pyrophosphate scintigraphy for the diagnosis of ATTR cardiac amyloidosis: comparison of quantitative and semi-quantitative approaches","volume":"27","author":"Regis","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03133-y_bib6","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s12350-020-02455-z","article-title":"Addendum to ASNC\/AHA\/ASE\/EANM\/HFSA\/ ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2\u2014evidence base and standardized methods of imaging","volume":"28","author":"Dorbala","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03133-y_bib7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s12350-020-02353-4","article-title":"Inter-observer reproducibility and intra-observer repeatability in 99mTc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis","volume":"29","author":"Singh","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03133-y_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-020-02201-5","article-title":"Diagnostic and prognostic value of Technetium-99m pyrophosphate uptake quantitation for transthyretin cardiac amyloidosis","volume":"29","author":"Miller","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03133-y_bib9","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s12350-019-01893-8","article-title":"Quantitative 99mTc-DPD SPECT\/CT in patients with suspected ATTR cardiac amyloidosis: feasibility and correlation with visual scores","volume":"27","author":"Caobelli","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03133-y_bib10","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jcmg.2020.03.020","article-title":"Quantification in cardiac amyloidosis. A novel imaging biomarker","volume":"13","author":"Scully","year":"2020","journal-title":"J Am Coll Cardiol Imaging"},{"key":"10.1007\/s12350-022-03133-y_bib11","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s12350-020-02274-2","article-title":"Quantitation of myocardial 99mTc-HMDP uptake with new SPECT\/CT cadmium zinc telluride (CZT) camera in patients with transthyretin-related cardiac amyloidosis: ready for clinical use?","volume":"29","author":"Bellevre","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03133-y_bib12","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1007\/s12350-021-02715-6","article-title":"An optimized imaging protocol for [99mTc]TcDPD scintigraphy and SPECT\/CT quantification in cardiac transthyretin (ATTR) amyloidosis","volume":"28","author":"Schatka","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03133-y_bib13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-022-03133-y_bib14","series-title":"Medcalc Statistical Software version 20.106","year":"2022"},{"key":"10.1007\/s12350-022-03133-y_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1007\/s12350-022-03133-y_bib16","article-title":"Prognostic value of 99mTc-HMDP Scintigraphy in elderly patients with chronic heart failure","author":"Uusitalo","year":"2021","journal-title":"Heart Lung Circ"},{"issue":"5","key":"10.1007\/s12350-022-03133-y_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/CRD.0000000000000387","article-title":"Transthyretin cardiac amyloidosis and novel therapies to treat this not-so-rare cause of cardiomyopathy","volume":"29","author":"Capustin","year":"2021","journal-title":"Cardiol Rev"},{"key":"10.1007\/s12350-022-03133-y_bib18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1007\/s12350-022-03133-y_bib19","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/CIRCULATIONAHA.119.045093","article-title":"Cost-effectiveness of tafamidis therapy for transthyretin amyloid cardiomyopathy","volume":"141","author":"Kazi","year":"2020","journal-title":"Circulation"},{"key":"10.1007\/s12350-022-03133-y_bib20","first-page":"234","article-title":"Regional variation in technetium pyrophosphate uptake in transthyretin cardiac amyloidosis and impact on mortality","volume":"11","author":"Sperry","year":"2018","journal-title":"JACC"},{"key":"10.1007\/s12350-022-03133-y_bib21","series-title":"Introduction to xSPECT* technology: evolving multi-modal SPECT to become context-based and quantitative. Siemens Healthcare White Paper.","author":"Vija","year":"2013"},{"key":"10.1007\/s12350-022-03133-y_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/RLU.0000000000003412","article-title":"Clinical assessment of 177Lu-DOTATATE quantification by comparison of SUV-based parameters measured on both post-PRRT SPECT\/CT and 68Ga-DOTATOC PET\/CT in patients with neuroendocrine tumors: a feasibility study","volume":"46","author":"Thuillier","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1007\/s12350-022-03133-y_bib23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MNM.0000000000000960","article-title":"Spatial dependence of activity concentration recovery for a conjugate gradient (Siemens xSPECT) algorithm using manufacturer-defined reconstruction presets","volume":"40","author":"Armstrong","year":"2019","journal-title":"Nucl Med Commun"},{"key":"10.1007\/s12350-022-03133-y_bib24","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/MNM.0000000000001059","article-title":"Quantitative SPECT: a survey of current practice in the UK Nuclear Medicine Community","volume":"40","author":"Dickson","year":"2019","journal-title":"Nuc Med Commun"},{"key":"10.1007\/s12350-022-03133-y_bib25","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s12350-020-02139-8","article-title":"Technetium pyrophosphate nuclear scintigraphy for cardiac amyloidosis: imaging at 1 vs 3 hours and planar vs SPECT\/CT","volume":"27","author":"Sperry","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03133-y_bib26","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s12350-020-02273-3","article-title":"Tc-99m-PYP imaging for cardiac amyloidosis: defining the best protocol before the flood gates burst","volume":"27","author":"Bokhari","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03133-y_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12350-019-01753-5","article-title":"Simultaneous Tc-99m PYP\/Tl-201 dual-isotope SPECT myocardial imaging in patients with suspected cardiac amyloidosis","volume":"27","author":"Tamarappoo","year":"2020","journal-title":"J Nucl Card"},{"key":"10.1007\/s12350-022-03133-y_bib28","first-page":"1364","article-title":"Quantitative bone-avid tracer SPECT\/CT for cardiac amyloidosis: a crucial step forward","volume":"13","author":"Dorbala","year":"2020","journal-title":"JACC"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-022-03133-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-022-03133-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123000302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123000302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-022-03133-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:11:40Z","timestamp":1761027100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123000302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1071358123000302"],"URL":"https:\/\/doi.org\/10.1007\/s12350-022-03133-y","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"99mTc-PYP SPECT and SPECT\/CT quantitation for diagnosing cardiac transthyretin amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-022-03133-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}